Evidence map›Paper›PMID 39763504›Full record

ArticleJournal of central nervous system disease2025

Transforming grayscale MRI images to color utilizing generative artificial intelligence to better understand multiple sclerosis.

Darin T Okuda, Christine Lebrun-Frénay

Abstract readCase Reports
In one paragraph

Article in Journal of central nervous system disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Darin T OkudaDepartment of Neurology, Neuroinnovation Program, Multiple Sclerosis & Neuroimmunology Imaging Program, The University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID https://orcid.org/0000-0002-6499-1523
Christine Lebrun-FrénayCRCSEP, Université Nice Cote d'Azur, Nice, France.ORCID https://orcid.org/0000-0002-3713-2416

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sclerosis (MS) falls within the spectrum of central nervous system (CNS) demyelinating diseases that may lead to permanent neurological disability. Fundamental to the diagnosis and clinical surveillance is magnetic resonance imaging (MRI) that allows for the identification of T2-hyperintensities associated with autoimmune injury that demonstrate distinct spatial distribution patterns. Here, we describe the clinical experience of a 31-year-old, right-handed, White man seen in consultation at The University of Texas Southwestern Medical Center in Dallas, Texas, following complaints of headaches that began after head trauma related to military service. Imaging data spanning over 10 years are provided. All MRI data are currently presented in black and white with grayscale values within voxels associated with a single variable, intensity. We transformed these grayscale values into color using generative artificial intelligence (AI). As color allows for the inclusion of three variables: hue, lightness (intensity), and saturation, we hypothesized that additional details may be learned beyond those currently provided with the existing conventional approach of grayscale interpretation. We identified differences in lesion colors that remained consistent from the two MRI timepoints studied. In addition, quantitative R1, R2, and proton density voxel values appeared consistent with the color scheme generated by the AI system. With advancing AI methods and capabilities along with the additional data that color provides in comparison to grayscale, new insights into the biology of disease may be possible. Modifying what we measure in people with chronic conditions and how we present the data may be of greater value than conventional approaches typically used in the study, education, and care of people with MS and other neurological conditions.

Indexed as

artificial intelligencecolorMRIMultiple sclerosis

Identifiers

PMID39763504
PMCPMC11701911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.